Results 201 to 210 of about 32,838 (276)

Hemp (Cannabis sativa L.) Seed Protein and Its Hydrolysate Promote Bone Formation via the SMAD‐Dependent BMP Pathway

open access: yesiNew Medicine, Volume 2, Issue 3, September 2026.
ABSTRACT Objective With the global increase in aging populations, the prevalence of osteoporosis is rising. Current preventive and therapeutic strategies remain limited. The present study aimed to investigate the effects of hemp seed protein (HSP) and its hydrolysis‐derived bioactive peptides (HPH) on osteogenic differentiation and to elucidate their ...
Yan Wang   +14 more
wiley   +1 more source

A tsRNA Suppresses Lung Adenocarcinoma Progression Through Targeting Glucose‐6‐Phosphate Dehydrogenase

open access: yesJournal of Biochemical and Molecular Toxicology, Volume 40, Issue 9, September 2026.
Structure of tsRNA‐Thr‐5‐0096. Mechanically, tsRNA‐Thr‐5‐0096 suppresses LUAD progression by targeting G6PD which regulates glycolysis and oxidative stress. ABSTRACT Elucidating the molecular distinctions between invasive and non‐invasive forms of lung adenocarcinoma is essential for the development of personalized therapeutic approaches and the ...
Suo Sha   +7 more
wiley   +1 more source

The Putative Effector Protein AlPE1 From Ascochyta lentis Causes Necrosis in Lentil and Pea

open access: yesLegume Science, Volume 8, Issue 3, September 2026.
ABSTRACT Ascochyta blight of lentil is caused by the hemibiotrophic fungal pathogen species Ascochyta lentis. Recent advances in whole genome sequencing have led to the availability of many fungal genome assemblies, enabling comparison of isolates that can lead to the identification of virulence genes or effectors.
Robert C. Lee   +4 more
wiley   +1 more source

Immune Checkpoint Inhibitors in Cancer Therapy: Clinical Landscape, Resistance Mechanisms, and Therapeutic Innovations

open access: yesMedComm – Oncology, Volume 5, Issue 3, September 2026.
The up‐to‐date clinical progress of immune checkpoint inhibitor (ICI) therapy in solid tumors, specifically the combinational regimens between ICIs and other treatment strategies, the mechanisms underlying primary and acquired resistance, and mechanism‐matched strategies to improve clinical outcomes are synthesized in this review.
Qiongyu Zhang, Zhi Qin, Caijuan Guo
wiley   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Paul and Apollos—Colleagues or Rivals?

Journal for the Study of the New Testament, 2000
Donald P. Ker
exaly   +2 more sources

Home - About - Disclaimer - Privacy